2′-fucosyllactose and Akkermansia muciniphila as a candidate synergistic synbiotic: mechanisms for gut health and immune modulation

The dynamic interplay between dietary glycans and commensal microorganisms fundamentally shapes host–microbiota homeostasis and immune regulation. This review examines the pairing of 2′-fucosyllactose (2′-FL), a predominant human milk oligosaccharide (HMO), and A. muciniphila , a mucin-degrading next-generation probiotic. We synthesize mechanistic evidence that 2′-FL can enrich A. muciniphila colonization and metabolic output in experimental systems. Most of this evidence is derived from in vitro and animal studies, whereas human evidence is limited to single-component interventions with either 2′-FL or A. muciniphila . Direct co-administration evidence remains limited: in a mouse colitis study from our group, co-administering 2′-FL with A. muciniphila enhanced anti-inflammatory effects and short-chain fatty acid production beyond bacterial monocolonization, and an independent mouse study reported improved colonization and colitis outcomes with combined administration. However, neither study reported formal statistical interaction testing, the synergistic finding awaits independent replication, and no human combination trial has been conducted. Accordingly, the proposed synergistic mechanisms remain provisional, and the efficacy of this candidate synbiotic requires validation in controlled combination experiments and human studies. This substrate–microbe axis may influence mucin-related and epithelial barrier functions and contribute to immune homeostasis through preparation- and context-dependent mechanisms. Furthermore, we critically evaluate translational implications for developing synbiotic functional food formulations, including effective dosing in adult populations, bioavailability, formulation stability, and safety considerations. By integrating nutritional glycobiology with microbiome science and probiotic technology, this work proposes a comprehensive conceptual framework for microbiota-based immune modulation and evidence-based functional food innovation.

Authors

Institutions

Publication Details

Journal
Frontiers in Nutrition
Published
2026-11-19
DOI
https://doi.org/10.3389/fnut.2026.1964310
Primary Topic
Gut microbiota and health
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

2′-fucosyllactose and Akkermansia muciniphila as a candidate synergistic synbiotic: mechanisms for gut health and immune modulation

Yuying Shuai, Yichao Ma, Yannan Jin
Frontiers in Nutrition
Gut microbiota and health
article

2′-fucosyllactose and Akkermansia muciniphila as a candidate synergistic synbiotic: mechanisms for gut health and immune modulation

Yuying Shuai, Yichao Ma, Yannan Jin
article en

Abstract

The dynamic interplay between dietary glycans and commensal microorganisms fundamentally shapes host–microbiota homeostasis and immune regulation. This review examines the pairing of 2′-fucosyllactose (2′-FL), a predominant human milk oligosaccharide (HMO), and A. muciniphila , a mucin-degrading next-generation probiotic. We synthesize mechanistic evidence that 2′-FL can enrich A. muciniphila colonization and metabolic output in experimental systems. Most of this evidence is derived from in vitro and animal studies, whereas human evidence is limited to single-component interventions with either 2′-FL or A. muciniphila . Direct co-administration evidence remains limited: in a mouse colitis study from our group, co-administering 2′-FL with A. muciniphila enhanced anti-inflammatory effects and short-chain fatty acid production beyond bacterial monocolonization, and an independent mouse study reported improved colonization and colitis outcomes with combined administration. However, neither study reported formal statistical interaction testing, the synergistic finding awaits independent replication, and no human combination trial has been conducted. Accordingly, the proposed synergistic mechanisms remain provisional, and the efficacy of this candidate synbiotic requires validation in controlled combination experiments and human studies. This substrate–microbe axis may influence mucin-related and epithelial barrier functions and contribute to immune homeostasis through preparation- and context-dependent mechanisms. Furthermore, we critically evaluate translational implications for developing synbiotic functional food formulations, including effective dosing in adult populations, bioavailability, formulation stability, and safety considerations. By integrating nutritional glycobiology with microbiome science and probiotic technology, this work proposes a comprehensive conceptual framework for microbiota-based immune modulation and evidence-based functional food innovation.

Frontiers in NutritionVol. 13
Zhejiang Chinese Medical University (CN)
Gut microbiota and health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon